Latest Breaking News On - Jorgea quiroz - Page 1 : comparemela.com

NMD Pharma to present NMD670 clinical data from a Phase I/IIa trial in myasthenia gravis at the 28th International Annual Congress of the World Muscle Society

NMD Pharma to present NMD670 clinical data from a Phase I/IIa trial in myasthenia gravis at the 28th International Annual Congress of the World Muscle Society
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Denmark
Charleston
South-carolina
United-states
Jorgea-quiroz
Lundbeckfonden-biocapital
Dan-brennan
International-congress
Company-phase
Roche-venture-fund
World-muscle-society-congress
Consilium-strategic-communications

NMD Pharma initiates Phase II trial of NMD670 in Spinal Muscular Atrophy

NMD Pharma initiates Phase II trial of NMD670 in Spinal Muscular Atrophy
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Leuven
Region-flamande
Belgium
United-states
Steigen
Baden-wüberg
Germany
Denmark
America
Dan-brennan
Kristl-claeys
Thomas-holm-pedersen

NMD Pharma to host a Satellite Symposium* and present new clinical data at the 148th Annual Meeting of the American Neurological Association

NMD Pharma to host a Satellite Symposium* and present new clinical data at the 148th Annual Meeting of the American Neurological Association
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United-states
Philadelphia
Pennsylvania
Denmark
American
America
Thomas-holm-pedersen
W-david-arnold
Jorgea-quiroz
Lundbeckfonden-biocapital
Franklin-hall
Dan-brennan

NMD Pharma Reports Results from the ESTABLISH Study – an International Observational Study of Neuromuscular Function in Charcot-Marie-Tooth Type 1 and 2

NMD Pharma Reports Results from the ESTABLISH Study – an International Observational Study of Neuromuscular Function in Charcot-Marie-Tooth Type 1 and 2
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

Ohio
United-states
Denmark
Copenhagen
Køavn
Columbus
Missouri
Ohio-state-university
America
Jorgea-quiroz
Pharma-reportsresults
Henning-andersen